Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sera Scandia is a Danish private company that produces and distributes biologically derived products for biotechnology, cell culture, pharma-related raw material applications, and nutrition markets. The company is best known as a supplier of animal sera, including fetal bovine serum, along with bovine serum albumin and other animal-derived proteins used in life science research and bioprocessing. Beyond life science tools, the group also upcycles animal by-products into food, feed, and nutrition ingredients. Sera Scandia appears to operate as a commercial-stage supplier rather than a therapeutic drug developer, so it does not have a conventional clinical pipeline. Its business is positioned at the intersection of biotech supply, protein ingredients, and animal-derived raw material sourcing with an emphasis on traceability and European sourcing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sera Scandia.